These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation. Anderson PR; Hanlon AL; Movsas B; Hanks GE Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1025-30. PubMed ID: 9392540 [TBL] [Abstract][Full Text] [Related]
9. Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir. Alexander AS; Mydin A; Jones SO; Christie J; Lim JT; Truong PT; Ludgate CM Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e713-9. PubMed ID: 21277102 [TBL] [Abstract][Full Text] [Related]
10. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766 [TBL] [Abstract][Full Text] [Related]
11. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. Zelefsky MJ; Lyass O; Fuks Z; Wolfe T; Burman C; Ling CC; Leibel SA J Clin Oncol; 1998 Oct; 16(10):3380-5. PubMed ID: 9779716 [TBL] [Abstract][Full Text] [Related]
12. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? Castle KO; Hoffman KE; Levy LB; Lee AK; Choi S; Nguyen QN; Frank SJ; Pugh TJ; McGuire SE; Kuban DA Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):693-9. PubMed ID: 22836052 [TBL] [Abstract][Full Text] [Related]
13. Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up. Gleave ME; La Bianca SE; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD Urology; 2000 Aug; 56(2):289-94. PubMed ID: 10925096 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435 [TBL] [Abstract][Full Text] [Related]
15. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy. Beyer DC; McKeough T; Thomas T Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331 [TBL] [Abstract][Full Text] [Related]
16. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer. D'Amico AV; Saegaert T; Chen MH; Renshaw AA; George D; Oh W; Kantoff PW Cancer; 2002 Jul; 95(2):275-80. PubMed ID: 12124826 [TBL] [Abstract][Full Text] [Related]
17. Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer. Crook J; Ludgate C; Malone S; Lim J; Perry G; Eapen L; Bowen J; Robertson S; Lockwood G Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):15-23. PubMed ID: 15337535 [TBL] [Abstract][Full Text] [Related]
19. Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy. Bracci S; Osti MF; Agolli L; Bertaccini L; De Sanctis V; Valeriani M Radiat Oncol; 2016 Jun; 11():78. PubMed ID: 27276878 [TBL] [Abstract][Full Text] [Related]
20. PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients. Oosterlinck W; Mattelaer J; Casselman J; Van Velthoven R; Derde MP; Kaufman L Acta Urol Belg; 1997 Oct; 65(3):63-71. PubMed ID: 9421938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]